Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bavarian Nordic A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bavarian Nordic A/S, Medical Devices Deals, 2012 to YTD 2018 10
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
PCI Biotech Enters into Research Agreement with Bavarian Nordic 13
Bavarian Nordic Enters into Agreement with US Department of Defense 14
Bavarian Nordic Enters into Partnership with Astrazeneca 15
SGS Partners with Bavarian Nordic 16
Bavarian Nordic Enters into Agreement with Roche 17
Bavarian Nordic Enters into Agreement with Evaxion Biotech and Technical University of Denmark 18
Licensing Agreements 19
Janssen Pharma Enters into Licensing Agreement with Bavarian Nordic 19
Bavarian Nordic Enters into Licensing Agreement with Valneva 20
Janssen Pharma Enters into Licensing Agreement with Bavarian Nordic 21
Bristol-Myers Squibb Enters into Option for Licensing Agreement with Bavarian Nordic 22
Bavarian Nordic Enters into Licensing Agreement with Crucell Holland 23
Bavarian Nordic Enters into Licensing Agreement with National Institutes of Health 24
Equity Offering 25
Bavarian Nordic Raises USD32.5 Million in Private Placement of Shares 25
Bavarian Nordic Raises USD101.8 Million in Private Placement of Shares 27
Bavarian Nordic Withdraws Public Offering of ADSs for up to USD86.3 Million 29
Bavarian Nordic Raises USD0.66 Million in Private Placement of Shares upon Exercise of Warrants 31
Bavarian Nordic Raises USD1.7 Million in Private Placement of Shares upon Exercise of Warrants 32
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants 33
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants 34
Bavarian Nordic Raises USD43 Million in Private Placement of Shares 35
Bavarian Nordic Raises USD3.8 Million in Private Placement of Shares upon Exercise of Warrants 36
Bavarian Nordic A/S – Key Competitors 37
Bavarian Nordic A/S – Key Employees 38
Bavarian Nordic A/S – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Aug 16, 2018: Bavarian Nordic announces first half 2018 results 40
May 24, 2018: Bavarian Nordic Announces Interim Results for the First Three Months of 2018 42
Mar 12, 2018: Bavarian Nordic Announces Annual Report 2017 44
Nov 08, 2017: Bavarian Nordic Announces Interim Results for the First Nine Months of 2017 46
Aug 25, 2017: Bavarian Nordic Announces First Half 2017 Results 47
May 04, 2017: Bavarian Nordic Announces Interim Results for the First Three Months of 2017 48
Mar 15, 2017: Bavarian Nordic Announces Annual Report 2016 49
Corporate Communications 50
May 31, 2018: Bavarian Nordic Appoints Henrik Juuel As Chief Financial Officer 50
Jan 31, 2018: Bavarian Nordic Announces Resignation Of Ole Larsen As Chief Financial Officer 51
May 10, 2017: Bavarian Nordic Announces Appointment of Dr. Tommi Kainu as Chief Business Officer 52
Jan 17, 2017: Henrik Birk Appointed Chief Operating Officer of Bavarian Nordic 53
Product News 54
09/27/2017: Bavarian Nordic Secures Contract Award for Supply of Freeze-dried IMVAMUNE Smallpox Vaccine to the U.S. Government 54
06/16/2017: Bavarian Nordic Announces Notification of Request for Proposal for Freeze-Dried IMVAMUNE 55
03/10/2017: Bavarian Nordic Announces Collaboration to Evaluate CV301 and Tecentriq in Bladder Cancer 56
Clinical Trials 57
Jun 19, 2018: Exploring a New Treatment for Metastatic Colorectal Cancer 57
Mar 08, 2018: Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite Stable Colorectal Cancer 58
Feb 06, 2018: Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE Smallpox Vaccine 59
Nov 21, 2017: Bavarian Nordic Announces Exercise of Clinical Option by the US Government under Contract for Freeze-dried IMVAMUNE Smallpox Vaccine 60
Mar 21, 2017: Direct Tumor Vaccination Shown to Induce Anti-tumor Immunity and Increase Survival in a Murine Model of Pancreatic Cancer 61
Jan 04, 2017: Bristol-Myers, Bavarian Nordic test Opdivo-plus-vaccine combo in lung cancer 62
Other Significant Developments 63
Aug 09, 2018: Bavarian Nordic granted EUR 30 million loan from The European Investment Bank 63
Mar 12, 2018: Bavarian Nordic Awards Restricted Stock Units to Executive Management 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bavarian Nordic A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bavarian Nordic A/S, Deals By Therapy Area, 2012 to YTD 2018 9
Bavarian Nordic A/S, Medical Devices Deals, 2012 to YTD 2018 10
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
PCI Biotech Enters into Research Agreement with Bavarian Nordic 13
Bavarian Nordic Enters into Agreement with US Department of Defense 14
Bavarian Nordic Enters into Partnership with Astrazeneca 15
SGS Partners with Bavarian Nordic 16
Bavarian Nordic Enters into Agreement with Roche 17
Bavarian Nordic Enters into Agreement with Evaxion Biotech and Technical University of Denmark 18
Janssen Pharma Enters into Licensing Agreement with Bavarian Nordic 19
Bavarian Nordic Enters into Licensing Agreement with Valneva 20
Janssen Pharma Enters into Licensing Agreement with Bavarian Nordic 21
Bristol-Myers Squibb Enters into Option for Licensing Agreement with Bavarian Nordic 22
Bavarian Nordic Enters into Licensing Agreement with Crucell Holland 23
Bavarian Nordic Enters into Licensing Agreement with National Institutes of Health 24
Bavarian Nordic Raises USD32.5 Million in Private Placement of Shares 25
Bavarian Nordic Raises USD101.8 Million in Private Placement of Shares 27
Bavarian Nordic Withdraws Public Offering of ADSs for up to USD86.3 Million 29
Bavarian Nordic Raises USD0.66 Million in Private Placement of Shares upon Exercise of Warrants 31
Bavarian Nordic Raises USD1.7 Million in Private Placement of Shares upon Exercise of Warrants 32
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants 33
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants 34
Bavarian Nordic Raises USD43 Million in Private Placement of Shares 35
Bavarian Nordic Raises USD3.8 Million in Private Placement of Shares upon Exercise of Warrants 36
Bavarian Nordic A/S, Key Competitors 37
Bavarian Nordic A/S, Key Employees 38
Bavarian Nordic A/S, Other Locations 39
Bavarian Nordic A/S, Subsidiaries 39
List of Figures
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bavarian Nordic A/S, Medical Devices Deals, 2012 to YTD 2018 10